A Study of LY317615 in Patients With Brain Tumors
1. The safety of LY317615 and any side effects that might be associated with the drug.
2. Whether LY317615, can help patients with brain tumors.
Malignant Glioma
DRUG: Enzastaurin
To establish data regarding the anti-tumor activity of LY317615 in patients with recurrent high-grade gliomas.
To obtain preliminary information regarding the spectrum of toxicities of LY317615 administered to patients with recurrent high-grade gliomas
1. The safety of LY317615 and any side effects that might be associated with the drug.
2. Whether LY317615, can help patients with brain tumors.